Article info

Download PDFPDF

Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats

Authors

  • Masataka Enomoto Translational Research in Pain, Comparative Pain Research and Education Centre, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA PubMed articlesGoogle scholar articles
  • Patrick W Mantyh Cancer Center’s Cancer Biology Program, Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona, USA PubMed articlesGoogle scholar articles
  • Joanna Murrell School of Veterinary Sciences, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles
  • John F Innes Units E&F, CVS Vets Ltd, Chester, UK PubMed articlesGoogle scholar articles
  • B Duncan X Lascelles Translational Research in Pain, Comparative Pain Research and Education Centre, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USAComparative Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USACenter for Pain Research and Innovation, UNC School of Dentistry, Chapel Hill, North Carolina, USACenter for Translational Pain Research, Department of Anesthesiology, Duke University, Durham, North Carolina, USA PubMed articlesGoogle scholar articles
  1. E-mail for correspondence; dxlascel{at}ncsu.edu
View Full Text

Citation

Enomoto, M., Mantyh, PW., Murrell, J., Innes, JF., Lascelles, BDX.
(2019) Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats

Publication history

  • Received June 26, 2017
  • Revision received July 10, 2018
  • Accepted September 19, 2018
  • First published October 27, 2018.
Online issue publication 
January 03, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.